abstract |
(57) Abstract: 2- [p- (4-benzhydrylpiperazinophenyl) ethylmethyl 2,6-dimethyl-4- (3-nitrophenyl) -1,4-dihydropyridine- [3,5-dicarboxylate] hydrochloride, oleic acid monoglyceride, polyoxyethylene sorbitan monooleate, and polyethylene glycol. [Effect] It is possible to reduce the dose of a poorly water-soluble drug such as a dihydropyridine derivative, thereby reducing pain and side effects of a patient when taking the drug. |